1. Home
  2. DEI vs OCUL Comparison

DEI vs OCUL Comparison

Compare DEI & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$12.14

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.65

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
OCUL
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
DEI
OCUL
Price
$12.14
$8.65
Analyst Decision
Hold
Strong Buy
Analyst Count
8
9
Target Price
$12.94
$23.56
AVG Volume (30 Days)
2.1M
2.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
7.06%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,003,982,000.00
$1,990,000.00
Revenue This Year
$1.70
$7.93
Revenue Next Year
$2.35
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
1.77
3.48
52 Week Low
$9.04
$6.23
52 Week High
$16.94
$16.44

Technical Indicators

Market Signals
Indicator
DEI
OCUL
Relative Strength Index (RSI) 51.63 41.25
Support Level $11.15 $7.77
Resistance Level $12.70 $9.93
Average True Range (ATR) 0.38 0.49
MACD -0.03 -0.16
Stochastic Oscillator 43.28 12.98

Price Performance

Historical Comparison
DEI
OCUL

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: